Skip to content
10-Q

Quarterly Report

ADIAL PHARMACEUTICALS, INC. ADIL

0001213900-25-075695

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 21.83M sh
Shares Diluted Q2 2025 · Jun 30, 2025 10.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.59M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.18M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.57M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.33M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.77M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $5.91M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.75M
Stockholders Equity Q2 2025 · Jun 30, 2025 $5.59M
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.13M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.07M
Stockholders Equity Q2 2025 · Jun 30, 2024 $4.28M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6.12M
Stockholders Equity Q2 2025 · Dec 31, 2023 $4.08M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.21M
Current Liabilities Q2 2025 · Dec 31, 2024 $975.86K
Total Liabilities Q2 2025 · Jun 30, 2025 $1.21M
Total Liabilities Q2 2025 · Dec 31, 2024 $975.86K
Current Assets Q2 2025 · Jun 30, 2025 $6.08M
Current Assets Q2 2025 · Dec 31, 2024 $4.06M
Total Assets Q2 2025 · Jun 30, 2025 $6.8M
Total Assets Q2 2025 · Dec 31, 2024 $5.04M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.49
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.59
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.50
Eps Basic Q2 2025 · Jun 30, 2025 −$0.18
Eps Basic Q2 2025 · Jun 30, 2025 −$0.49
Eps Basic Q2 2025 · Jun 30, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2024 −$2.50
Sga Expense Q2 2025 · Jun 30, 2025 $1.15M
Sga Expense Q2 2025 · Jun 30, 2025 $2.67M
Sga Expense Q2 2025 · Jun 30, 2024 $1.27M
Sga Expense Q2 2025 · Jun 30, 2024 $2.67M
Rd Expense Q2 2025 · Jun 30, 2025 $732.32K
Rd Expense Q2 2025 · Jun 30, 2025 $1.48M
Rd Expense Q2 2025 · Jun 30, 2024 $1.01M
Rd Expense Q2 2025 · Jun 30, 2024 $1.47M
Net Income Q2 2025 · Jun 30, 2025 −$1.96M
Net Income Q2 2025 · Jun 30, 2025 −$4.19M
Net Income Q2 2025 · Mar 31, 2025 −$2.23M
Net Income Q2 2025 · Jun 30, 2024 −$2.46M
Net Income Q2 2025 · Jun 30, 2024 −$8.93M
Net Income Q2 2025 · Mar 31, 2024 −$6.48M
Operating Income Q2 2025 · Jun 30, 2025 −$1.88M
Operating Income Q2 2025 · Jun 30, 2025 −$4.15M
Operating Income Q2 2025 · Jun 30, 2024 −$2.29M
Operating Income Q2 2025 · Jun 30, 2024 −$4.13M